Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Metagenomic sequencing offers a powerful approach for the comprehensive monitoring and detection of pathogenic bacteria in food, clinical samples, and the environment.